DERIVADOS DE PIRAZOL FUSIONADOS
Se proporcionan compuestos de la fórmula (I) sales o solvatos, o derivados fisiológicamente funcionales de los mismos, en donde Z es CH o NH y R1, R2 y R4 son diversos grupos sustituyentes, y son inhibidores de proteína cinasa. Compounds of Formula (I): salts or solvates or physiologically functiona...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | spa |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | MICHAEL JOHN ALBERTI DAVID KENDALL JUNG JENNIFER BADIANG STANFORD JENNIFER BAIANG STANFORD IAN ROBERT BALDWIN MUI CHEUNG STEPHEN FLACK PHILIP ANTHONY HARRIS STUART COCKERILL MICHAEL ROBERT PEEL KIRK STEVENS JAMES MARVIN VEAL GREGORY PECKHAM |
| description | Se proporcionan compuestos de la fórmula (I) sales o solvatos, o derivados fisiológicamente funcionales de los mismos, en donde Z es CH o NH y R1, R2 y R4 son diversos grupos sustituyentes, y son inhibidores de proteína cinasa.
Compounds of Formula (I): salts or solvates or physiologically functional derivatives thereof, wherein Z is CH or N, and R1, R2, and R4 are various substituent groups, are protein kinase inhibitors |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_UY26899A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>UY26899A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_UY26899A13</originalsourceid><addsrcrecordid>eNrjZJB3cQ3yDHN08Q9WcHFVCPAMcozy91FwCw329PcDifIwsKYl5hSn8kJpbgY5N9cQZw_d1IL8-NTigsTk1LzUkvjQSCMzC0tLR0NjggoAIhMgxg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>DERIVADOS DE PIRAZOL FUSIONADOS</title><source>esp@cenet</source><creator>MICHAEL JOHN ALBERTI ; DAVID KENDALL JUNG ; JENNIFER BADIANG STANFORD ; JENNIFER BAIANG STANFORD ; IAN ROBERT BALDWIN ; MUI CHEUNG ; STEPHEN FLACK ; PHILIP ANTHONY HARRIS ; STUART COCKERILL ; MICHAEL ROBERT PEEL ; KIRK STEVENS ; JAMES MARVIN VEAL ; GREGORY PECKHAM</creator><creatorcontrib>MICHAEL JOHN ALBERTI ; DAVID KENDALL JUNG ; JENNIFER BADIANG STANFORD ; JENNIFER BAIANG STANFORD ; IAN ROBERT BALDWIN ; MUI CHEUNG ; STEPHEN FLACK ; PHILIP ANTHONY HARRIS ; STUART COCKERILL ; MICHAEL ROBERT PEEL ; KIRK STEVENS ; JAMES MARVIN VEAL ; GREGORY PECKHAM</creatorcontrib><description>Se proporcionan compuestos de la fórmula (I) sales o solvatos, o derivados fisiológicamente funcionales de los mismos, en donde Z es CH o NH y R1, R2 y R4 son diversos grupos sustituyentes, y son inhibidores de proteína cinasa.
Compounds of Formula (I): salts or solvates or physiologically functional derivatives thereof, wherein Z is CH or N, and R1, R2, and R4 are various substituent groups, are protein kinase inhibitors</description><edition>7</edition><language>spa</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2002</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20020322&DB=EPODOC&CC=UY&NR=26899A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,781,886,25569,76552</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20020322&DB=EPODOC&CC=UY&NR=26899A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>MICHAEL JOHN ALBERTI</creatorcontrib><creatorcontrib>DAVID KENDALL JUNG</creatorcontrib><creatorcontrib>JENNIFER BADIANG STANFORD</creatorcontrib><creatorcontrib>JENNIFER BAIANG STANFORD</creatorcontrib><creatorcontrib>IAN ROBERT BALDWIN</creatorcontrib><creatorcontrib>MUI CHEUNG</creatorcontrib><creatorcontrib>STEPHEN FLACK</creatorcontrib><creatorcontrib>PHILIP ANTHONY HARRIS</creatorcontrib><creatorcontrib>STUART COCKERILL</creatorcontrib><creatorcontrib>MICHAEL ROBERT PEEL</creatorcontrib><creatorcontrib>KIRK STEVENS</creatorcontrib><creatorcontrib>JAMES MARVIN VEAL</creatorcontrib><creatorcontrib>GREGORY PECKHAM</creatorcontrib><title>DERIVADOS DE PIRAZOL FUSIONADOS</title><description>Se proporcionan compuestos de la fórmula (I) sales o solvatos, o derivados fisiológicamente funcionales de los mismos, en donde Z es CH o NH y R1, R2 y R4 son diversos grupos sustituyentes, y son inhibidores de proteína cinasa.
Compounds of Formula (I): salts or solvates or physiologically functional derivatives thereof, wherein Z is CH or N, and R1, R2, and R4 are various substituent groups, are protein kinase inhibitors</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2002</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJB3cQ3yDHN08Q9WcHFVCPAMcozy91FwCw329PcDifIwsKYl5hSn8kJpbgY5N9cQZw_d1IL8-NTigsTk1LzUkvjQSCMzC0tLR0NjggoAIhMgxg</recordid><startdate>20020322</startdate><enddate>20020322</enddate><creator>MICHAEL JOHN ALBERTI</creator><creator>DAVID KENDALL JUNG</creator><creator>JENNIFER BADIANG STANFORD</creator><creator>JENNIFER BAIANG STANFORD</creator><creator>IAN ROBERT BALDWIN</creator><creator>MUI CHEUNG</creator><creator>STEPHEN FLACK</creator><creator>PHILIP ANTHONY HARRIS</creator><creator>STUART COCKERILL</creator><creator>MICHAEL ROBERT PEEL</creator><creator>KIRK STEVENS</creator><creator>JAMES MARVIN VEAL</creator><creator>GREGORY PECKHAM</creator><scope>EVB</scope></search><sort><creationdate>20020322</creationdate><title>DERIVADOS DE PIRAZOL FUSIONADOS</title><author>MICHAEL JOHN ALBERTI ; DAVID KENDALL JUNG ; JENNIFER BADIANG STANFORD ; JENNIFER BAIANG STANFORD ; IAN ROBERT BALDWIN ; MUI CHEUNG ; STEPHEN FLACK ; PHILIP ANTHONY HARRIS ; STUART COCKERILL ; MICHAEL ROBERT PEEL ; KIRK STEVENS ; JAMES MARVIN VEAL ; GREGORY PECKHAM</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_UY26899A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>spa</language><creationdate>2002</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>MICHAEL JOHN ALBERTI</creatorcontrib><creatorcontrib>DAVID KENDALL JUNG</creatorcontrib><creatorcontrib>JENNIFER BADIANG STANFORD</creatorcontrib><creatorcontrib>JENNIFER BAIANG STANFORD</creatorcontrib><creatorcontrib>IAN ROBERT BALDWIN</creatorcontrib><creatorcontrib>MUI CHEUNG</creatorcontrib><creatorcontrib>STEPHEN FLACK</creatorcontrib><creatorcontrib>PHILIP ANTHONY HARRIS</creatorcontrib><creatorcontrib>STUART COCKERILL</creatorcontrib><creatorcontrib>MICHAEL ROBERT PEEL</creatorcontrib><creatorcontrib>KIRK STEVENS</creatorcontrib><creatorcontrib>JAMES MARVIN VEAL</creatorcontrib><creatorcontrib>GREGORY PECKHAM</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>MICHAEL JOHN ALBERTI</au><au>DAVID KENDALL JUNG</au><au>JENNIFER BADIANG STANFORD</au><au>JENNIFER BAIANG STANFORD</au><au>IAN ROBERT BALDWIN</au><au>MUI CHEUNG</au><au>STEPHEN FLACK</au><au>PHILIP ANTHONY HARRIS</au><au>STUART COCKERILL</au><au>MICHAEL ROBERT PEEL</au><au>KIRK STEVENS</au><au>JAMES MARVIN VEAL</au><au>GREGORY PECKHAM</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>DERIVADOS DE PIRAZOL FUSIONADOS</title><date>2002-03-22</date><risdate>2002</risdate><abstract>Se proporcionan compuestos de la fórmula (I) sales o solvatos, o derivados fisiológicamente funcionales de los mismos, en donde Z es CH o NH y R1, R2 y R4 son diversos grupos sustituyentes, y son inhibidores de proteína cinasa.
Compounds of Formula (I): salts or solvates or physiologically functional derivatives thereof, wherein Z is CH or N, and R1, R2, and R4 are various substituent groups, are protein kinase inhibitors</abstract><edition>7</edition><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | spa |
| recordid | cdi_epo_espacenet_UY26899A1 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | DERIVADOS DE PIRAZOL FUSIONADOS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-15T14%3A09%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=MICHAEL%20JOHN%20ALBERTI&rft.date=2002-03-22&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUY26899A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |